COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,555 Articles (22,400 medRxiv, 8,155 bioRxiv)

Most recent first Previous |  Page 2726: Articles 27251-27260  | Next

Two alternative scenarios for easing COVID-19 lockdown measures: one reasonable and one catastrophic
Fokas, A. S., Cuevas-Maraver, J., Kevrekidis, P. G.
10.1101/2020.05.08.20095380 — Posted: 2020-05-12
Significant Relaxation of SARS-CoV-2-Targeted Non-Pharmaceutical Interventions Will Result in Profound Mortality: A New York State Modelling Study
Hoffman, B. U.
10.1101/2020.05.08.20095505 — Posted: 2020-05-12
A two-wave epidemiological model of COVID-19 outbreaks using MS-Excel(R)
De Noni, A., da Silva, B. A., Dal-Pizzol, F., Porto, L. M.
10.1101/2020.05.08.20095133 — Posted: 2020-05-12
Estimation of the number of general anesthesia cases based on a series of nationwide surveys on Twitter during COVID-19 in Japan: A statistical analysis
Daijo, H., Fujii, Y., Hirota, K.
10.1101/2020.05.08.20094979 — Posted: 2020-05-12
Lactate arterial-central venous gradient among COVID-19 patients in ICU: a potential tool in the clinical practice.
Nardi, G., Sanson, G., Tassinari, L., Guiotto, G., Potalivo, A., Montomoli, J., Schiraldi, F.
10.1101/2020.05.08.20095042 — Posted: 2020-05-12
Clinical, Radiological and Therapeutic Characteristics of Patients with COVID-19 in Saudi Arabia
Shabrawishi, M., Al-Gethamy, M. M., Naser, A. Y., Ghazawi, M. A., Alsharif, G. F., Obaid, E. F., Melebari, H. A., Alamri, D. M., Brinji, A. S., Al Jehani, F. H., Almaimani, W., Ekram, R. A., Alkhatib, K. H., Alwafi, H.
10.1101/2020.05.07.20094169 — Posted: 2020-05-12
Stability of SARS-CoV-2 on environmental surfaces and in human excreta
Liu, Y., Li, T., Deng, Y., Liu, S., Zhang, D., Li, H., Wang, X., Jia, L., Han, J., Bei, Z., Zhou, Y., Li, L., Li, J.
10.1101/2020.05.07.20094805 — Posted: 2020-05-12 Discussion: Offsite
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.
Rojek, A., Martin, G., Horby, P.
10.1101/2020.05.07.20094839 — Posted: 2020-05-12
Clinical Course and Risk Factors for Recurrence of Positive SARS-CoV-2 RNA: A Retrospective Cohort Study from Wuhan, China
Chen, J., Xu, X., Hu, J., Chen, Q., Xu, F., Liang, H., Liu, N., Zhu, H., Lan, J., Zhou, L., Xing, J., Pu, N., Cai, Z.
10.1101/2020.05.08.20095018 — Posted: 2020-05-12
Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study.
Sanchez-Montalva, A., Selares-Nadal, J., Espinosa-Pereiro, J., Fernandez-Hidalgo, N., Perez-Hoyos, S., Salvador, F., Dura-Miralles, X., Miarons, M., Anton, A., Eremiev, S., Sempere-Gonzalez, A., Bosch-Nicolau, P., Monforte-Pallares, A., Augustin, S., Sampol, J., Guillen-del-Castillo, A., Almirante, B.
10.1101/2020.05.07.20094599 — Posted: 2020-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).